\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Horizon EuropeMore Horizon Europe documents are published step by step. Following the publication of the Horizon Europe work programme 2021-2022 on 15 June, the Horizon Europe programme guide was launched. It is a roughly 60 pages guide and offers “detailed guidance on the structure, budget and political priorities and other relevant background of the Horizon Europe programme relevant for preparing the proposal.” The guidance contains information on a broad variety of topics such as partnerships and missions, gender equality and open science. The document is complementary to the Funding and Tenders portal 2021-2027 online manual, the general annexes of the Horizon Europe work programme 2021-2022 and the annotated grant agreement (AGA) which is not yet published.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The European Commission has recently published the first amendment to the Digital Europe Main Work Programme 2025-2027, taking into account the most recent political priorities of the Commission. Among the main changes, the programme will now contribute to the landmark AI Gigafactories initiative, set to accelerate the development of cutting... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
